Other drugs may be available that can treat your condition
Kevin Jones, MD Medical Director, Flow Wellness "We can look at their muscle mass, their fat mass, visceral fat the fat that's around your organs
Although there is strong evidence supporting the benefit of GLP-1RAs in populations with obesity, their efficacy in other populations of particular HF subtypes and specific cardiomyopathies is unclear
Some considerations for lower-BMI use include: helping to break long-standing weight loss plateaus, weight maintenance after dieting, and reduction in compulsive or binge eating
Care at Geneva is guided by: In-house lab testing to assess metabolic health, insulin sensitivity, and relevant risk factors Metabolic and hormone evaluation to understand drivers of appetite, weight regulation, and energy balance Regular physician follow-ups to monitor response, tolerance, and long-term progress Flexible medication pathways that allow adjustments based on how each patient responds over time Rather than defaulting to a single medication, Geneva physicians evaluate whether a patient is more likely to benefit from a traditional GLP-1 medication or from tirzepatide
This small molecule is composed of three amino acids: cysteine, glutamine, and glycine, and it acts as a shield against the damaging effects of free radicals, toxins, and pollutants